Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Viral Diseases”

28,382 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 28,382 results

Testing effectiveness (Phase 2)Study completedNCT07329907
What this trial is testing

Combination Therapy for Warts: Candida Antigen vs. Topical Keratolytic

Who this might be right for
WartsHuman Papilloma Virus (HPV)
Benha University 126
Testing effectiveness (Phase 2)Looking for participantsNCT05086692
What this trial is testing

A Beta-only IL-2 ImmunoTherapY Study

Who this might be right for
Advanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more
Medicenna Therapeutics, Inc. 115
Not applicableEnrolling By InvitationNCT05463692
What this trial is testing

CAMELLIA Cohort: A Longitudinal Study to Understand Sexual Health and Prevention Among Women in Alabama

Who this might be right for
HivSexually Transmitted Diseases
University of Alabama at Birmingham 830
Large-scale testing (Phase 3)Study completedNCT00000700
What this trial is testing

A Multi-Center Clinical Trial To Evaluate Azidothymidine (AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Infection in Patients With AIDS Post First Episode PCP

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 482
Large-scale testing (Phase 3)Ended earlyNCT05247307
What this trial is testing

Efficacy of the Infusion of Donor Plasma in COVID-19 Infection

Who this might be right for
COVID-19
Hospital Galdakao-Usansolo 93
Not applicableUnknownNCT04589936
What this trial is testing

Prone Position to Improve Oxygenation in COVID-19 Patients Outside Critical Care

Who this might be right for
PneumoniaCovid19
Cambridge University Hospitals NHS Foundation Trust 56
Large-scale testing (Phase 3)Study completedNCT00000136
What this trial is testing

Studies of the Ocular Complications of AIDS (SOCA)--Foscarnet-Ganciclovir CMV Retinitis Trial (FGCRT)

Who this might be right for
HIV InfectionsCytomegalovirus Retinitis
Johns Hopkins Bloomberg School of Public Health 234
Early research (Phase 1)Study completedNCT00043511
What this trial is testing

Safety of an HIV DNA Vaccine Given to HIV Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 30
Not applicableUnknownNCT05186571
What this trial is testing

Myopericarditis After Messenger Ribonucleic Acid (mRNA) COVID-19 Vaccination in Children 5-11 Years Old

Who this might be right for
MyopericarditisMyocarditisVaccination; Complications+2 more
Rigshospitalet, Denmark 350,000
Not applicableUnknownNCT04568044
What this trial is testing

Evaluation of Humoral Immunity Following COVID-19 in Pregnancy

Who this might be right for
COVID-19Pregnancy RelatedInfluenza, Human
Imperial College London 128
Testing effectiveness (Phase 2)Study completedNCT00312936
What this trial is testing

A Mindfulness Based Approach to HIV Treatment Side Effects

Who this might be right for
HIV Infections
University of California, San Francisco 76
Not applicableStudy completedNCT04303507
What this trial is testing

Chloroquine/ Hydroxychloroquine Prevention of Coronavirus Disease (COVID-19) in the Healthcare Setting

Who this might be right for
COVID19CoronavirusAcute Respiratory Illnesses
University of Oxford 4,652
Post-approval studies (Phase 4)Ended earlyNCT01606800
What this trial is testing

Efficacy and Safety of Short Course Therapy With Peginterferon Alpha-2b (PEG-IFN Alfa-2b) and Ribavirin (RBV) for Chronic Hepatitis C (Genotype 4) Participants Achieving a Rapid Virological Response at Week 4 of Treatment (MK-8908B-059)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 45
Not applicableActive Not RecruitingNCT06109571
What this trial is testing

Clinic-level Implementation of mHealth to Improve HIV Viral Suppression for Patients With Substance Use Disorders

Who this might be right for
HIV InfectionsSubstance Use Disorders
University of Wisconsin, Madison 433
Post-approval studies (Phase 4)Study completedNCT00227500
What this trial is testing

Pravastatin for Hyperlipidaemia in HIV.

Who this might be right for
HIV InfectionsLipid MetabolismGlucose Metabolism+3 more
Kirby Institute 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT05453500
What this trial is testing

Chemotherapy (DA-EPOCH+/-R) and Targeted Therapy (Tafasitamab) for the Treatment of Newly-Diagnosed Philadelphia Chromosome Negative B Acute Lymphoblastic Leukemia

Who this might be right for
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
University of Washington 32
Not applicableStudy completedNCT06016192
What this trial is testing

Aerobic Training for Rehabilitation of Patients With Post Covid-19 Syndrome

Who this might be right for
Post-COVID-19 SyndromeLong-COVID-19 Syndrome
University of Witten/Herdecke 139
Not applicableStudy completedNCT00870792
What this trial is testing

Physician Focused Intervention to Improve Adherence With HIV Antiretrovirals

Who this might be right for
HIV InfectionHIV Infections
National Institute on Drug Abuse (NIDA) 156
Early research (Phase 1)Study completedNCT01070407
What this trial is testing

A New Candidate Vaccine Against Hepatitis C Virus (HCV)

Who this might be right for
Hepatitis C
ReiThera Srl 41
Testing effectiveness (Phase 2)Ended earlyNCT05543707
What this trial is testing

PBI-0451 (Pomotrelvir) Phase 2 Study in Nonhospitalized Symptomatic Adults With COVID-19

Who this might be right for
COVID-19
Pardes Biosciences, Inc. 242
Next Page